Each year, this scholarship is awarded to an exceptional student in memory of Kevin Child. Below is the list of previous recipients.Learn MoreThe Kevin Child Scholarship has been bestowing awards annually since 1990. It is only made possible through…
The foundation's staff is comprised of dedicated people use their talents to help the blood and bleeding disorders community. One of them is Karina Lopez, MPH!
Karina joined us to talk about her progression from an internship to a full-time…
In 2013, for the first time, the Kevin Child Scholarship was awarded to two brothers with severe hemophilia A - Gabriel Forbes had been a freshman at Whittier College majoring in kinesiology with a minor in French at the time of his award. He was…
Recombinant Factor VIII Fc Fusion Protein for First-time Immune Tolerance
Speaker: Lynn Malec, MD, MSc
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to…
The Evidence for Shared-Decision Making for Hemophilia Gene Therapy
Speaker: Dr. Courtney Thornburg
NHF's Wednesday Webinars are a free education series open to providers and community…
FOR IMMEDIATE RELEASE
Ilana Ostrin
Senior Director of Public Relations and Communications
iostrin@hemophilia.org
212-328-3769
Upcoming Wednesday Webinar Schedule Released
Free series continues throughout spring and summer months…
Learn More About HEMA Biologic’s Latest Treatment Option for the Hemophilia Community
Speaker: Dr. Guy Young
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and…
You’re invited to NHF’s Spring '23 Research Journal Club (RJC) event on Thursday, May 25th at 2:00pm EST. Don’t miss this special discussion titled "My Life Our Future Repository Study: HLA Variants and Inhibitor Development in Hemophilia A: A…
Gene Therapy: A Breakthrough Era for Hemophilia B. Introducing Hemgenix®️ (Etranacogene Dezaparvovec-Drlb)
Speaker(s): Dr. Guy Young, Dr. Tammuella Singleton, and Dr. Debra Bensen-Kennedy
NHF's Wednesday Webinars are a free…